DRKS00030861招募中不适用
Collection of blood samples for research and development of an IP-10 TB-CLIA-Assay - TB-CLIA-1
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •General inclusion criteria:
- •Ability to understand and sign a written subject information and informed consent form
- •women and men over 18 years old
- •collection of the necessary volume of whole blood possible
- •Only for TB-positive subjects
- •active or latent infection with tuberculosis
- •diagnosis of active tuberculosis: confirmed by clinical symptoms and molecular evidence (by PCR) or by cultural detection or by microscopic detection or by radiological examination
- •latent TB-infection: confirmed by IGRA or Tuberkulin skin test
- •Only for TB-negative subjects
- •no clinical or pathological test result or anamnestic data indicating active or latent infection with M. tuberculosis
排除标准
- •pregnant or breastfeeding women
- •An event or finding, due to which the subject is not suitable for the participation in the study in the opinion of the principal investigator
研究者
相似试验
已完成
不适用
Collection of blood samples for analytical performance evaluation under the IVDR of in vitro test systems in the area of Allergy and Nutrition CareAllergiesFood IntoleranceDRKS00024808R-Biopharm AG26
招募中
不适用
Collection of blood samples for the evaluation of the analytical performance of two new in vitro test systems for tuberculosis diagnosticsA15-A19TuberculosisDRKS00027129R-Biopharm AG636
进行中（未招募）
Unknown
Blood collection for the development of a point-of-care troponin platformDiagnosis of myocardial infarctionCirculatory SystemISRCTN13589405Psyros Diagnostics120
招募中
不适用
Study of blood and sputum samples of healthy humans and patients for cancer research.CTRI/2023/01/048765Oxford Cancer Analytics
已完成
不适用
Trial for collection of blood samples from healed Covid-19 patients - research and development of in-vitro diagnosticsSARS-CoV-2 infectionCovid-19U07.1COVID-19, virus identifiedDRKS00022406R-Biopharm AG50